Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy

Abstract

Stereotactic therapy is a feasible conversion therapy for HCC patients with extrahepatic metastases to become resectable. This is the first study to analyse therapeutic outcomes of patients receiving these therapies for HCC with extrahepatic metastases.